tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports

Silexion Therapeutics (SLXN) Income Statement

214 Followers

Silexion Therapeutics Income Statement

Last quarter (Q4 2025), Silexion Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Silexion Therapeutics's net income was $-4.41M. See Silexion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -14.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.63M$ 12.57M$ 4.68M$ 3.86M$ 943.93K
Depreciation and Amortization
$ 14.00K$ 25.00K$ 45.00K$ 57.00K$ 0.00
EBITDA
$ -11.62M$ -16.48M$ -4.64M$ -3.80M$ -755.00K
Operating Income
$ -11.63M$ -12.57M$ -4.68M$ -3.86M$ -943.93K
Other Income/Expenses
$ -277.00K$ -3.94M$ -395.00K$ 396.00K$ 188.72K
Pretax Income
$ -11.91M$ -16.51M$ -5.08M$ -3.46M$ -755.22K
Net Income
$ -11.91M$ -16.44M$ -4.94M$ -3.21M$ -755.22K
Per Share Metrics
Basic EPS
$ -8.96$ -2.64$ -4.42$ 0.03$ -0.05
Diluted EPS
$ -8.96$ -2.64$ -4.42$ 0.03$ -0.05
Weighted Average Shares Outstanding
 1.33M 6.24M 1.12M 16.73M 16.51M
Weighted Average Shares Outstanding (Diluted)
 1.33M 6.24M 1.12M 16.73M 16.51M
Currency in USD

Silexion Therapeutics Earnings and Revenue History